One weightlifter describes months of fatigue and twitching after BPC-157, as an FDA panel votes to ease limits on six unapproved peptides.
Recap by typeshit. Full story at Yahoo News Singapore.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A $90 Brooklyn vial held a filler used in lip balm plus 13 bacteria colonies, University of Iowa testers said. Two online orders shipped with no consultation.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
Partnership for Safe Medicines also notes Eli Lilly suing five more retatrutide sellers and FDA staff concerns over a plan to let compounders dispense unapproved peptides.
A decade-old skin plumping ingredient found new demand from GLP-1 users with hollow cheeks. More than 150 companies now use it, Estée Lauder included.
Loading…